Emergency heart valve replacement study for severe aortic stenosis
Part of Heart & circulation clinical trials.
This study looks at how safe and effective an emergency heart valve replacement is for people with severe aortic stenosis who are in critical condition. It may help if you have severe symptoms like shock or unstable chest pain that need urgent treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aortic stenosis, a condition where the heart valve is very narrow, confirmed by tests like an echocardiogram.
- You need emergency treatment because you are in shock, have dangerous heart rhythms, or have unstable chest pain or heart failure not helped by medicines.
- You are willing to sign a consent form and follow the study procedures and follow-up visits.
- You cannot take part if your heart anatomy is not suitable for the new valve, if you have a blood clot in your heart, or if you have an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients getting a new heart valve (transcatheter aortic valve implantation) for severe aortic stenosis. It aims to understand long-term outcomes and safety in a real-world registry.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study checks whether an “investigational” transcatheter aortic valve is safe and works well for people with severe, calcified aortic stenosis (a stiff, narrowed heart valve). It may help improve valve function and symptoms, but you must meet specific heart, scan, and health-status requirements.
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
This trial tests a new valve device placed through a small tube (catheter) to treat severe aortic stenosis, a condition where the aortic valve is narrowed and doesn't open fully. It's for patients who cannot have traditional open-heart surgery.
This trial tests if surgery to replace your aortic valve is safe and effective for people with severe aortic stenosis who are at low risk for complications. It compares surgery to another procedure to see which works best.
Hear when a new Severe Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.